🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’re excited to attend the Lupus Research LuCIN Community Meeting and come together on the latest advancements for lupus patients. Learn more about our progress in #autoimmune diseases including lupus: bit.ly/4bH1loK #LuCINCommunity #LupusTherapeutics

In honor of #WomensHistoryMonth, last week our We-GEM group hosted Tasneem Chopra for a powerful conversation on DEI and also led a company-wide giving back event in partnership with Life Science Cares Boston to make care kits for women supported by local nonprofit Victory Programs .

#NationalMinorityCancerAwarenessMonth recognizes cancer care disparities impacting people from racial and ethnic minority groups. We commit to efforts to increase access, expand clinical trial participation, and address needs for underserved communities. #MinorityHealth

Tune in on Wednesday, April 9, to hear our CSO Jennifer Michaelson share her perspective on overcoming barriers and navigating uncertainty while advancing cutting edge-science. Join Fierce Fierce Life Sciences Events free virtual event.

Collaboration is at the core of what we do, because together, we can impact more lives through exceptional science. Our diverse team of experts across disciplines continuously empowers innovation through open dialogue and respect to pioneer novel therapies.

On April 29, the Lupus Foundation of America will bring together leading experts and the lupus community to share the latest research advancements for potential new treatments. Listen in to the thoughtful discussion during this free webinar!

Today, we announced we received approval from the European Medicines Agency (EMA) to initiate our Phase 1 clinical trial assessing CLN-978 in patients with active, difficult-to-treat rheumatoid arthritis. Learn more.

Hear Professor Ricardo Grieshaber-Bouyer, MD PhD, MHBA, share his clinical perspective as he discusses the need for new therapies for patients with rheumatoid arthritis with Jeff Jones, MD, MBA, our Chief Medical Officer.

On April 24, Patrick Baeuerle, PhD, our Chief Scientific Advisor, will present about the potential of T cell engagers in #autoimmune diseases at the World Congress on Immunology in Paris. Learn more.

Today, we announced that results from the REZILIENT1 study in patients with non-small cell lung cancer (NSCLC) will be presented in an oral abstract session at #ASCO25 on Sunday, June 1. Learn more about our presence at the meeting.

On May 1, join Chief Medical Officer Jeff Jones, MD, MBA and the #lupus community for  Lupus Research’s free webinar event to learn more about T cell engagers as an emerging cell therapy and hear perspectives from individuals living with lupus. Register now!

On Saturday, #TeamCullinan came together for The Leukemia & Lymphoma Society #BigClimb. We’re proud to support the LLS and their critical work for blood cancer patients and their families. Congratulations and thanks to all the amazing climbers!

Today, we announced we are initiating a U.S. study of CLN-978, our investigational CD19 T cell engager, in patients with Sjögren’s disease. Learn more.

Our diversified pipeline includes clinical-stage oncology assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells. Learn more about how we leverage our scientific excellence to develop transformative therapeutics.

In honor of National Cancer Research Month, see why Kerry Whalen, Senior Director, Program Management, and Shengting Li, Vice President, Clinical Development, believe supporting cancer research is so critical for breakthroughs. #NCRM25

Announced today, our corporate update and Q1 2025 financial results showcase our significant advancements as we continue to progress our diversified pipeline in autoimmune diseases and cancer. Learn more.

On #WorldLupusDay, we remain committed to working collaboratively to raise awareness about this complex disease and improve quality of life for those living with lupus. Learn more about our efforts to #MakeLupusVisible and address unmet patient need. #LupusAwarenessMonth

We were honored to celebrate Yue Zhang, Senior Director, Clinical Research Scientist, for being recognized as a 2025 Rising Star at the HBAnet's 35th Annual Women of the Year event. Congratulations, Yue! #HBAimpact #HBAWOTY25

This #LupusAwarenessMonth, we encourage you to learn more and raise awareness about the complexities of lupus. Every day, as we work toward breakthroughs, we are driven by the goal of improving the lives of those living with autoimmune diseases like lupus.

This week our We-GEM Community welcomed local artist Diana Stelin for a “Reducing Burnout Through Art” workshop. Participants engaged in immersive painting exercises that promote mindfulness, relaxation, and self-discovery. Thank you, Diana! dianastelin.com